Starch Medical (San Jose, California), a device company developing and manufacturing absorbable hemostatic products, is adding China to its strategic focus, hoping to take advantage of China's ongoing and rapid shift from manufacturing to new product development.

HONG KONG – Underscoring the clouds hanging over China’s pharmaceutical and biotechnology industries, Shanghai Pharmaceuticals Holding Co Ltd. reported double-digit growth in the third quarter of the year, but the mostly positive results were tarred by coming in below expectations.

Low-end medical device exporters are heading into the second session of the largest import and export fair in China in a gloomy mood.

Entering the South Korean market is now easier for makers of low-risk medical devices. The country's Ministry of Food and Drug Safety (MFDS) updated its regulations last month and dropped a number of inspection and registration requirements for all Class I devices. Korean medical devices are classified into four categories based on the risk level. Class I devices are considered low risk, There are two kinds of Class I devices, regular and specially controlled.